These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 15850275)

  • 1. [The treatment of chronic hepatitis C virus infection in children].
    Koot BG; Benninga MA; Weegink CJ; Peters M
    Ned Tijdschr Geneeskd; 2005 Apr; 149(15):832-5. PubMed ID: 15850275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic hepatitis C virus infection - Dutch national guidelines.
    de Bruijne J; Buster EH; Gelderblom HC; Brouwer JT; de Knegt RJ; van Erpecum KJ; Schalm SW; Bakker CM; Zaaijer HL; Janssen HL; Reesink HW;
    Neth J Med; 2008; 66(7):311-22. PubMed ID: 18663263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ribavirin in the treatment of hepatitis C.
    Abonyi ME; Lakatos PL
    Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute hepatitis C: prevention and treatment.
    Ozaras R; Tahan V
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):351-61. PubMed ID: 19344247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severity of liver disease predicts the development of glucose abnormalities in patients with chronic hepatitis B or C following achievement of sustained virological response to antiviral therapy.
    Chehadeh W; Al-Nakib W
    J Med Virol; 2009 Apr; 81(4):610-8. PubMed ID: 19235842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
    Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
    Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic hepatitis C.
    Lo Re V; Kostman JR
    Postgrad Med J; 2005 Jun; 81(956):376-82. PubMed ID: 15937203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C virus virology and new treatment targets.
    Meier V; Ramadori G
    Expert Rev Anti Infect Ther; 2009 Apr; 7(3):329-50. PubMed ID: 19344246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is serum uric acid a predictive factor of response to IFN-treatment in patients with chronic hepatitis C infection?
    Pellicano R; Puglisi G; Ciancio A; Balzola F; Saracco G; Ciccone G; Baldi I; Abate ML; Smedile A; Rizzetto M
    J Med Virol; 2008 Apr; 80(4):628-31. PubMed ID: 18297716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral therapy for recurrent hepatitis C after liver transplantation: sustained virologic response is related to genotype 2/3 and response at week 12.
    Raziorrouh B; Jung MC; Schirren CA; Loehe F; Thiel M; Nitschko H; Diepolder H; Ulsenheimer A; Heeg M; Zachoval R; Gruener NH
    Eur J Gastroenterol Hepatol; 2008 Aug; 20(8):778-83. PubMed ID: 18617783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin: a new independent predictor of liver steatosis and response to IFN-alpha treatment in chronic hepatitis C.
    Zografos TA; Liaskos C; Rigopoulou EI; Togousidis E; Makaritsis K; Germenis A; Dalekos GN
    Am J Gastroenterol; 2008 Mar; 103(3):605-14. PubMed ID: 18190648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML; Chuang WL; Dai CY; Lee LP; Hsieh MY; Lin ZY; Chen SC; Hsieh MY; Wang LY; Chang WY; Tsai SL; Kuo HT
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estimating the impact of hepatitis C virus therapy on future liver-related morbidity, mortality and costs related to chronic hepatitis C.
    Buti M; San Miguel R; Brosa M; Cabasés JM; Medina M; Angel Casado M; Fosbrook L; Esteban R
    J Hepatol; 2005 May; 42(5):639-45. PubMed ID: 15826711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Which patients with hepatitis C virus should be treated?
    Shamoun DK; Anania FA
    Semin Gastrointest Dis; 2000 Apr; 11(2):84-95. PubMed ID: 10803633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Know your enemy: translating insights about the molecular biology of hepatitis C virus into novel therapeutic approaches.
    von Hahn T; Steinmann E; Ciesek S; Pietschmann T
    Expert Rev Gastroenterol Hepatol; 2010 Feb; 4(1):63-79. PubMed ID: 20136590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NASPGHAN practice guidelines: Diagnosis and management of hepatitis C infection in infants, children, and adolescents.
    Mack CL; Gonzalez-Peralta RP; Gupta N; Leung D; Narkewicz MR; Roberts EA; Rosenthal P; Schwarz KB;
    J Pediatr Gastroenterol Nutr; 2012 Jun; 54(6):838-55. PubMed ID: 22487950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hepatitis C virus ten years after its discovery].
    Bralet MP; Dhumeaux D; Zafrani ES
    Ann Pathol; 1999 Dec; 19(6):499-512. PubMed ID: 10617807
    [No Abstract]   [Full Text] [Related]  

  • 19. Chronic hepatitis C virus infection in children.
    Mohan N; González-Peralta RP; Fujisawa T; Chang MH; Heller S; Jara P; Kelly D; Mieli-Vergani G; Shah U; Murray KF
    J Pediatr Gastroenterol Nutr; 2010 Feb; 50(2):123-31. PubMed ID: 20038846
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C in children--diagnosis, follow-up and treatment].
    Rojahn A; Wathne KO
    Tidsskr Nor Laegeforen; 2002 Aug; 122(20):1985-8. PubMed ID: 12555443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.